WHITNEY GIAUQUE: Open Payments
NPI 1558142034 · GLASTONBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,336 in 156 payments from 20 companies in 2025. Trend: 2023 $29 · 2024 $3,079 · 2025 $3,336
Food & beverage: $3,336
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $514 |
| LEO Pharma Inc. | 23 | $485 |
| Janssen Biotech, Inc. | 24 | $454 |
| UCB, Inc. | 16 | $392 |
| Regeneron Healthcare Solutions, Inc. | 9 | $276 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $229 |
| Galderma Laboratories, L.P. | 15 | $192 |
| Botanix SB Inc | 3 | $136 |
| E.R. Squibb & Sons, L.L.C. | 6 | $118 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 5 | $101 |
Products named: TREMFYA, Bimzelx, RINVOQ, DUPIXENT, ADBRY, SKYRIZI, ILUMYA, ANZUPGO.
Industry payments across CT — which companies pay providers there.
